CA
PLSE icon

Cliff Asness’s Pulse Biosciences PLSE Stock Holding History

Cliff Asness’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
+8,566
New +$202K ﹤0.01% 3733
2025
Q2 		– Sell
-10,162
Closed -$164K – 3366
2025
Q1 		$164K Sell
10,162
-505
-5% -$9.41K ﹤0.01% 2929
2024
Q4 		$186K Buy
10,667
+10
+0.1% +$176 ﹤0.01% 2684
2024
Q3 		$187K Sell
10,657
-538
-5% -$9.17K ﹤0.01% 2586
2024
Q2 		$125K Sell
11,195
-1,766
-14% -$16.6K ﹤0.01% 2476
2024
Q1 		$113K Buy
+12,961
New +$119K ﹤0.01% 2326
2018
Q4 		– Sell
-17,309
Closed -$246K – 2256
2018
Q3 		$246K Sell
17,309
-15,227
-47% -$216K ﹤0.01% 2156
2018
Q2 		$493K Sell
32,536
-17,176
-35% -$291K ﹤0.01% 1983
2018
Q1 		$673K Buy
49,712
+6,358
+15% +$121K ﹤0.01% 1816
2017
Q4 		$1.02M Buy
43,354
+24,432
+129% +$577K ﹤0.01% 1670
2017
Q3 		$352K Buy
18,922
+10,565
+126% +$240K ﹤0.01% 2041
2017
Q2 		$289K Buy
+8,357
New +$230K ﹤0.01% 2050

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Cliff Asness's PLSE Position: Q2 2026 in Review

Cliff Asness opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 8,566 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #3733 among its holdings. This is a return to the name: Cliff Asness previously reported a position in PLSE as recently as Q1 2025.

Cliff Asness first reported a position in PLSE in Q2 2017 and has held it in 12 quarters since. The position peaked at $1.02M in Q4 2017. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Cliff Asness held 8,566 shares of Pulse Biosciences worth $238K as of Q2 2026.
  • Pulse Biosciences was a new Cliff Asness position in Q2 2026.
  • Pulse Biosciences made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3733 holding.
  • Cliff Asness first reported a position in Pulse Biosciences in Q2 2017 and has held it in 12 quarters since.
  • Cliff Asness's Pulse Biosciences position peaked at $1.02M in Q4 2017.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.